BLT
28/01/2016 14:31
GENERAL
NOT PRICE SENSITIVE
REL: 1431 HRS BLIS Technologies Limited
GENERAL: BLT: Blis Technologies Gets Key 'Letter of No Objection' From US
Announcement
January 28, 2016
Blis Technologies Gets Key 'Letter of No Objection' From US Food and Drug
Administration for Ingredient BLIS K12
Blis Technologies Limited announces that one of the company's key products,
the ingredient BLIS K12, has had the issuance of a US Food and Drug
Administration 'Letter of No Objection'.
The Letter of No Objection, more commonly known as GRAS or 'Generally
Recognized As Safe', is another step on the strategic pathway to open markets
through regulatory approval.
It adds a new level of credibility for BLIS K12 and has the potential to put
the conversations with larger consumer food and beverage companies in the US
on a stronger footing.
Many of those companies are, quite rightly, risk averse and therefore having
GRAS status offers an additional level of confidence. GRAS status makes it
clearer where BLIS K12 fits within the category.
Through the GRAS program, companies may submit their determination supported
by research and expert review that a specific ingredient is Generally
Recognized As Safe. The Letter of No Objection means that the FDA has
reviewed the data and has no questions regarding the notice submitted.
Peter Fennessy
Chairman
End CA:00276923 For:BLT Type:GENERAL Time:2016-01-28 14:31:25
